Tech Company Financing Transactions
AltheaDx Funding Round
Private investors participated in a $27 million Series C capital raise for AltheaDx. This venture round was announced on 4/25/2017.
Transaction Overview
Company Name
Announced On
4/25/2017
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series C
Investors
Proceeds Purpose
The Series D funding will provide operating capital as AltheaDx expands its sales force and scales up marketing efforts following the successful completion of its pivotal double-blinded randomized controlled neuropsychiatric clinical trial for which the company now awaits a local coverage determination from CMS. The Company has also initiated discussions with various partners to expand internationally.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10578 Science Center Dr. 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
AltheaDx provides molecular biomarker discovery, assay development and validation, clinical trial testing and companion diagnostics development services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Nikodem
Chief Operating Officer
Feng Cao
Browse more venture capital transactions:
Prev: 4/25/2017: Central Logic venture capital transaction
Next: 4/25/2017: VacationFutures venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs